SeeSAR as a tool for compound prioritization

webinar

Thu, 05 Mar 2015, 19:00 CET (Berlin)

Dr. Carsten Detering, BioSolveIT GmbH, St. Augustin, Germany

SeeSAR as a tool for compound prioritization

With today’s pharma projects under increased pressure, it is necessary to put more emphasis on how the medicinal chemists can be helped achieve their goals faster. Given the vast amount of compounds medicinal chemists have to deal with, it is difficult to synthesize them all or make an informed decision, respectively, which ones to further pursue.
SeeSAR is a tool for the medicinal chemist which lets them sketch out ideas for compound modifications and which tells them right away if the modifications made are beneficial for the affinity. Intuitive visual representation suggests where to optimize, and why. SeeSAR is a tool for 21st century research.

  • ROI after only 5 syntheses spared by SeeSAR
  • easiest user interface in the industry
  • interactive usage, fast and intuitive results

Who should attend?
Computational and medicinal chemists, crystallographers, managers, everybody interested in modern drug discovery.

Why should you attend?
If you want to learn about software tools of the 21st century, this webinar is a must.

Current news

Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on
category
Events
DrugSpace 2026 Symposium - The Path to Digital Chemistry
October 6, 2026 11:28 CEST
Where Medicinal and Computational Chemistry Come Together We are delighted to invite drug hunters, compound enthusiasts, and molecule designers back to the virtual DrugSpace Symposium. The fifth edition takes place on December 9, 2026, under the theme “The Path to Digital Chemistry,” and turns the spotlight on where computational and...
Read on
category
Events
BioSolveIT at the Enamine Drug Discovery Conference 2026 in Riga
September 23, 2026 16:21 CEST
The Enamine Drug Discovery Conference in Riga (Latvia) comes to a close today. Our CEO Dr. Christian Lemmen and our SVP Application Science Dr. Marcus Gastreich spent the past four days, 20 to 23 September 2026, at the Radisson Blu Latvija Conference & Spa Hotel, and they return with much...
Read on